Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders

CNS Neuroscience and Therapeutics

Volumn 20, Issue 7, 2014, Pages 582-590

  Naumenko, Vladimir S ^a   Popova, Nina K ^a   Lacivita, Enza ^b   Leopoldo, Marcello ^b   Ponimaskin, Evgeni G ^c  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b UNIVERSITY OF BARI   (Italy)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Depression; G protein coupled receptor (GPCR); Receptor dimerization; Serotonin

Indexed keywords

HETERODIMER; HOMODIMER; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

BRAIN REGION; CROSS REACTION; DEPRESSION; DIMERIZATION; HETERODIMERIZATION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; NONHUMAN; OLIGOMERIZATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DEPRESSIVE DISORDER; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

ANIMALS; BRAIN; DEPRESSIVE DISORDER; HUMANS; PROTEIN MULTIMERIZATION; RECEPTOR CROSS-TALK; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84902529368     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12247     Document Type: Review

References (130)

1. Humphrey PP, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993;14:233-236.
2. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
3. Saudou F, Hen R. 5-Hydroxytryptamine receptor subtypes: Molecular and functional diversity. Adv Pharmacol 1994;30:327-380.
4. Popova NK, Naumenko VS. 5-HT1A receptor as a key player in the brain 5-HT system. Rev Neurosci 2013;24:191-204.
5. Bonaventure P, Dugovic C, Kramer M, et al. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder. J Pharmacol Exp Ther 2012;342:429-440.
6. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG. 5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern. Biol Psychiatry 2005;58:831-837.
7. Thomas DR, Hagan JJ. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004;3:81-90.
8. Azmitia PM, Witaker-Azmitia EC. Anatomy, cell biology and plasticity of the serotonergic system. Neuropsychopharmacological implications for the action of psychotropic drugs. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995;443-449.
9. Rasmuson S, Olsson T, Henriksson BG, et al. Environmental enrichment selectively increases 5-HT1A receptor mRNA expression and binding in the rat hippocampus. Brain Res Mol Brain Res 1998;53:285-290.
10. Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: Guilt by association. Neuroscientist 2004;10:575-593.
11. Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 2003;53:193-203.
12. Hong CJ, Chen TJ, Yu YW, Tsai SJ. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006;6:27-33.
13. Lemonde S, Turecki G, Bakish D, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23:8788-8799.
14. Meltzer HY, Sumiyoshi T. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res 2008;195:98-102.
15. Kobilka BK, Frielle T, Collins S, et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 1987;329:75-79.
16. Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 1988;335:358-360.
17. Albert PR, Zhou QY, Van Tol HH, Bunzow JR, Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 1990;265:5825-5832.
18. Charest A, Wainer BH, Albert PR. Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line. J Neurosci 1993;13:5164-5171.
19. Oakey RJ, Caron MG, Lefkowitz RJ, Seldin MF. Genomic organization of adrenergic and serotonin receptors in the mouse: Linkage mapping of sequence-related genes provides a method for examining mammalian chromosome evolution. Genomics 1991;10:338-344.
20. Ou XM, Jafar-Nejad H, Storring JM, Meng JH, Lemonde S, Albert PR. Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem 2000;275:8161-8168.
21. Storring JM, Charest A, Cheng P, Albert PR. TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. J Neurochem 1999;72:2238-2247.
22. Wu S, Comings DE. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999;9:105-106.
23. Lemonde S, Du L, Bakish D, Hrdina P, Albert PR. Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 2004;7:501-506.
24. Pucadyil TJ, Kalipatnapu S, Chattopadhyay A. The serotonin1A receptor: A representative member of the serotonin receptor family. Cell Mol Neurobiol 2005;25:553-580.
25. Riad M, Watkins KC, Doucet E, Hamon M, Descarries L. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 2001;21:8378-8386.
26. Knapp DJ, Overstreet DH, Crews FT. Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Brain Res 1998;782:1-10.
27. Hall H, Lundkvist C, Halldin C, et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res 1997;745:96-108.
28. Takano H, Ito H, Takahashi H, et al. Serotonergic neurotransmission in the living human brain: A positron emission tomography study using [(1)(1)C]dasb and [(1)(1)C]WAY100635 in young healthy men. Synapse 2011;65:624-633.
29. Arango V, Underwood MD, Boldrini M, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25:892-903.
30. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998;18:7394-7401.
31. Shively CA, Friedman DP, Gage HD, et al. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. Arch Gen Psychiatry 2006;63:396-403.
32. Lanzenberger R, Baldinger P, Hahn A, et al. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry 2013;18:93-100.
33. Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 1993;268:23422-23426.
34. Lovenberg TW, Baron BM, de Lecea L, et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993;11:449-458.
35. Plassat JL, Amlaiky N, Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol Pharmacol 1993;44:229-236.
36. Kobe F, Guseva D, Jensen TP, et al. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci 2012;32:2915-2930.
37. Kvachnina E, Liu G, Dityatev A, et al. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci 2005;25:7821-7830.
38. Ponimaskin EG, Profirovic J, Vaiskunaite R, Richter DW, Voyno-Yasenetskaya TA. 5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein. J Biol Chem 2002;277:20812-20819.
39. 2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J Biol Chem 1998;273:17469-17476.
40. Leopoldo M, Lacivita E, Berardi F, Perrone R, Hedlund PB. Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther 2011;129:120-148.
41. Erdmann J, Nothen MM, Shimron-Abarbanell D, et al. The human serotonin 7 (5-HT7) receptor gene: Genomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder. Mol Psychiatry 1996;1:392-397.
42. Heidmann DE, Metcalf MA, Kohen R, Hamblin MW. Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organization. J Neurochem 1997;68:1372-1381.
43. Ikeda M, Iwata N, Kitajima T, et al. Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 2006;31:866-871.
44. Heidmann DE, Szot P, Kohen R, Hamblin MW. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 1998;37:1621-1632.
45. Liu H, Irving HR, Coupar IM. Expression patterns of 5-HT7 receptor isoforms in the rat digestive tract. Life Sci 2001;69:2467-2475.
46. Guthrie CR, Murray AT, Franklin AA, Hamblin MW. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J Pharmacol Exp Ther 2005;313:1003-1010.
47. Horisawa T, Ishiyama T, Ono M, Ishibashi T, Taiji M. Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: Analysis by [3H]SB-269970 autoradiography. Prog Neuropsychopharmacol Biol Psychiatry 2013;40:132-137.
48. Duncan MJ, Congleton MR. Neural mechanisms mediating circadian phase resetting by activation of 5-HT(7) receptors in the dorsal raphe: Roles of GABAergic and glutamatergic neurotransmission. Brain Res 2010;1366:110-119.
49. Duncan MJ, Short J, Wheeler DL. Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters. Brain Res 1999;829:39-45.
50. Cifariello A, Pompili A, Gasbarri A. 5-HT(7) receptors in the modulation of cognitive processes. Behav Brain Res 2008;195:171-179.
51. Liu J, Jordan LM. Stimulation of the parapyramidal region of the neonatal rat brain stem produces locomotor-like activity involving spinal 5-HT7 and 5-HT2A receptors. J Neurophysiol 2005;94:1392-1404.
52. Takeda H, Tsuji M, Ikoshi H, et al. Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice. Eur J Pharmacol 2005;518:30-39.
53. Gellynck E, Heyninck K, Andressen KW, et al. The serotonin 5-HT7 receptors: Two decades of research. Exp Brain Res 2013;230:555-568.
54. Middlemiss DN, Fozard JR. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 1983;90:151-153.
55. Dourish CT, Ahlenius S, Hutson PH, editors. Brain 5-HT1A receptors. Chichester, UK: Ellis Horwood Ltd, 1987;26-33.
56. 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 1985;44:1685-1696.
57. Ruat M, Traiffort E, Leurs R, et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 1993;90:8547-8551.
58. Fletcher A, Forster EA, Bill DJ, et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 1996;73:337-353.
59. Fletcher A, Bill DJ, Bill SJ, et al. WAY100135: A novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur J Pharmacol 1993;237:283-291.
60. Assie MB, Koek W. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur J Pharmacol 1996;304:15-21.
61. Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA. NAN-190: Agonist and antagonist interactions with brain 5-HT1A receptors. Brain Res 1990;532:191-196.
62. Johansson L, Sohn D, Thorberg SO, et al. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 1997;283:216-225.
63. Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE. WAY-100635 is a potent dopamine D4 receptor agonist. Psychopharmacology 2006;188:244-251.
64. Shen Y, Monsma FJ Jr, Metcalf MA, Jose PA, Hamblin MW, Sibley DR. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 1993;268:18200-18204.
65. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacology 1994;33:275-317.
66. Freret T, Paizanis E, Beaudet G, et al. Modulation of 5-HT receptor: Effect on object recognition performances in mice. Psychopharmacology 2013;231:393-400.
67. Costa L, Spatuzza M, D'Antoni S, et al. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. Biol Psychiatry 2012;72:924-933.
68. Costa L, Trovato C, Musumeci SA, Catania MV, Ciranna L. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus 2012;22:790-801.
69. Eriksson TM, Holst S, Stan TL, et al. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: Implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology 2012;63:1150-1160.
70. Brenchat A, Romero L, Garcia M, et al. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 2009;141:239-247.
71. Hedlund PB, Leopoldo M, Caccia S, et al. LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor. Neurosci Lett 2010;481:12-16.
72. Hagan JJ, Price GW, Jeffrey P, et al. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 2000;130:539-548.
73. Thomas DR, Gittins SA, Collin LL, et al. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br J Pharmacol 1998;124:1300-1306.
74. Thomas DR, Melotto S, Massagrande M, et al. SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 2003;139:705-714.
75. Goodwin GM, De Souza RJ, Green AR, Heal DJ. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 1987;91:506-511.
76. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J Neural Transm 1985;61:131-135.
77. Overstreet DH, Rezvani AH, Knapp DJ, Crews FT, Janowsky DS. Further selection of rat lines differing in 5-HT-1A receptor sensitivity: Behavioral and functional correlates. Psychiatr Genet 1996;6:107-117.
78. Popova NK, Naumenko VS, Plyusnina IZ, Kulikov AV. Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. J Neurosci Res 2005;80:286-292.
79. Naumenko VS, Tkachev SE, Kulikov AV, et al. The brain 5-HT1A receptor gene expression in hibernation. Genes Brain Behav 2008;7:300-305.
80. Hedlund PB, Danielson PE, Thomas EA, Slanina K, Carson MJ, Sutcliffe JG. No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci USA 2003;100:1375-1380.
81. Carley DW, Radulovacki M. Role of peripheral serotonin in the regulation of central sleep apneas in rats. Chest 1999;115:1397-1401.
82. Yoshioka M, Goda Y, Togashi H, Matsumoto M, Saito H. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J Pharmacol Exp Ther 1992;260:917-924.
83. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 2004;487:125-132.
84. Naumenko VS, Kondaurova EM, Popova NK. On the role of brain 5-HT7 receptor in the mechanism of hypothermia: Comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor. Neuropharmacology 2011;61:1360-1365.
85. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 2004;25:481-486.
86. Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 2005;26:131-137.
87. Devi LA. Heterodimerization of G-protein-coupled receptors: Pharmacology, signaling and trafficking. Trends Pharmacol Sci 2001;22:532-537.
88. Rivero-Muller A, Chou YY, Ji I, et al. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA 2010;107:2319-2324.
89. Gonzalez-Maeso J, Ang RL, Yuen T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008;452:93-97.
90. Waldhoer M, Fong J, Jones RM, et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA 2005;102:9050-9055.
91. Franco R, Casado V, Cortes A, et al. G-protein-coupled receptor heteromers: Function and ligand pharmacology. Br J Pharmacol 2008;153(Suppl 1):S90-S98.
92. Rozenfeld R, Devi LA. Receptor heteromerization and drug discovery. Trends Pharmacol Sci 2010;31:124-130.
93. Fuxe K, Ferre S, Canals M, et al. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 2005;26:209-220.
94. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 2000;20:RC110.
95. Hornigold DC, Mistry R, Raymond PD, Blank JL, Challiss RA. Evidence for cross-talk between M2 and M3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells. Br J Pharmacol 2003;138:1340-1350.
96. Israilova M, Tanaka T, Suzuki F, Morishima S, Muramatsu I. Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells. J Pharmacol Exp Ther 2004;309:259-266.
97. Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 2003;64:1317-1324.
98. Lee SP, So CH, Rashid AJ, et al. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004;279:35671-35678.
99. Kobe F, Renner U, Woehler A, et al. Stimulation- and palmitoylation-dependent changes in oligomeric conformation of serotonin 5-HT1A receptors. Biochim Biophys Acta 2008;1783:1503-1516.
100. Woehler A, Wlodarczyk J, Ponimaskin EG. Specific oligomerization of the 5-HT1A receptor in the plasma membrane. Glycoconj J 2009;26:749-756.
101. Ganguly S, Clayton AH, Chattopadhyay A. Organization of higher-order oligomers of the serotonin(1)(A) receptor explored utilizing homo-FRET in live cells. Biophys J 2011;100:361-368.
102. Paila YD, Kombrabail M, Krishnamoorthy G, Chattopadhyay A. Oligomerization of the serotonin(1A) receptor in live cells: A time-resolved fluorescence anisotropy approach. J Phys Chem B 2011;115:11439-11447.
103. Gorinski N, Kowalsman N, Renner U, et al. Computational and experimental analysis of the transmembrane domain 4/5 dimerization interface of the serotonin 5-HT(1A) receptor. Mol Pharmacol 2012;82:448-463.
104. Teitler M, Toohey N, Knight JA, Klein MT, Smith C. Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: Radioligand binding and functional evidence for GPCR homodimer protomer interactions. Psychopharmacology 2010;212:687-697.
105. Smith C, Toohey N, Knight JA, Klein MT, Teitler M. Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine(7) receptors: Evidence for in situ G protein-coupled receptor homodimer protomer cross-talk. Mol Pharmacol 2011;79:318-325.
106. Renner U, Zeug A, Woehler A, et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J Cell Sci 2012;125:2486-2499.
107. Kofuji P, Davidson N, Lester HA. Evidence that neuronal G-protein-gated inwardly rectifying K+ channels are activated by G beta gamma subunits and function as heteromultimers. Proc Natl Acad Sci USA 1995;92:6542-6546.
108. Reuveny E, Slesinger PA, Inglese J, et al. Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits. Nature 1994;370:143-146.
109. Aznar S, Qian Z, Shah R, Rahbek B, Knudsen GM. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 2003;959:58-67.
110. Beck SG, Choi KC, List TJ. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 1992;263:350-359.
111. Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolanos F, Schechter L. The central 5-HT1A receptors: Pharmacological, biochemical, functional, and regulatory properties. Ann N Y Acad Sci 1990;600:114-129; discussion 29-31.
112. Riad M, Garcia S, Watkins KC, et al. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000;417:181-194.
113. Jolas T, Haj-Dahmane S, Kidd EJ, et al. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 1994;268:1432-1443.
114. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 1995;352:141-148.
115. Beique JC, Campbell B, Perring P, et al. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: Coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 2004;24:4807-4817.
116. Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 2006;70:1013-1021.
117. Richardson-Jones JW, Craige CP, Guiard BP, et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010;65:40-52.
118. Hsiung SC, Adlersberg M, Arango V, Mann JJ, Tamir H, Liu KP. Attenuated 5-HT1A receptor signaling in brains of suicide victims: Involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 2003;87:182-194.
119. Lopez-Figueroa AL, Norton CS, Lopez-Figueroa MO, et al. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004;55:225-233.
120. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 2000;27:499-507.
121. Neumeister A, Young T, Stastny J. Implications of genetic research on the role of the serotonin in depression: Emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology 2004;174:512-524.
122. Sargent PA, Kjaer KH, Bench CJ, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000;57:174-180.
123. Li YC, Wang FM, Pan Y, et al. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:435-449.
124. Mullins UL, Gianutsos G, Eison AS. Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 1999;21:352-367.
125. Guscott M, Bristow LJ, Hadingham K, et al. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 2005;48:492-502.
126. Millan MJ, Canton H, Gobert A, et al. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: A comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther 1994;268:337-352.
127. Sundaram H, Newman-Tancredi A, Strange PG. Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms. Biochem Pharmacol 1993;45:1003-1009.
128. Lovell PJ, Bromidge SM, Dabbs S, et al. A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). J Med Chem 2000;43:342-345.
129. Forbes IT, Dabbs S, Duckworth DM, et al. (R)-3, N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: The first selective 5-HT7 receptor antagonist. J Med Chem 1998;41:655-657.
130. Forbes IT, Douglas S, Gribble AD, et al. SB-656104-A: A novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett 2002;12:3341-3344.